MILLENNIUM MANAGEMENT LLC 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 4:34 pm Sale |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 3,403,530 1.700% |
-6,772,999 (-66.56%) |
Filing |
| 2024-06-12 4:26 pm Purchase |
2024-06-10 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 10,176,529 5.400% |
6,532,578 (+179.27%) |
Filing |
| 2024-01-17 5:01 pm Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 3,643,951 3.200% |
-1,722,501 (-32.10%) |
Filing |
| 2023-08-29 4:17 pm Purchase |
2023-08-28 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 5,366,452 5.000% |
143,013 (+2.74%) |
Filing |
| 2023-08-28 4:13 pm Purchase |
2023-08-21 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 5,223,439 4.900% |
1,599,537 (+44.14%) |
Filing |
| 2023-01-20 4:13 pm Purchase |
2023-01-11 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 3,623,902 4.900% |
3,623,902 (New Position) |
Filing |